In today’s drug development environment, bioanalytical and stability challenges can make or break a drug platform. In-depth knowledge across a variety of technologies and methods, together with regulatory acceptance criteria are critical for success. Trust the know-how and guidance of experienced bioanalytical consultants to help navigate pharmaceutical development and the rapidly expanding world of traditional small molecule drugs and therapeutic proteins spanning monoclonal antibodies, biosimilars and antibody- drug conjugates.
Bioanalysis matters more than ever. We act as your guide and partner, helping organizations of all sizes select a drug development path, build product development strategy, and stay compliant with ever-increasing regulatory complexity and scrutiny.
BioData Solutions offers expertise and hands-on guidance in three disciplines:
Neal Sharpe, Ph.D.,
Principal at NA Sharpe Pharma LLC
– Biotechnology company developing
therapeutics in oncology
Gurudatt Chandorkar, PhD
Director, Clinical Pharmacology